TLK1抑制通过CHK1激活增强深紫外线辐射的抗癌效应
Yoshio Koike1, Toshio Kokuryo2, Junpei Yamaguchi1
1Division of Surgical Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Anticancer research
|June 26, 2024
概括
深紫外线 (DUV) 照射在胰腺癌中触发了托斯莱德样激酶1 (TLK1) 酸化. 抑制TLK1增强了DUV诱导的亡,并显示了胰腺癌治疗的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 深紫外线 (DUV) 发光二极管 (LED) 在250-350nm之间发射辐射.
- 托斯勒样酶1 (TLK1) 是一种核酶,涉及到细胞对DUV辐射的反应,特别是在癌症中.
研究的目的:
- 为了研究TLK1和DUV辐射诱导的癌细胞DNA损伤之间的相互作用.
- 评估在胰腺癌中将DUV照射与TLK1抑制相结合的治疗潜力.
主要方法:
- 胰腺癌细胞系暴露于带有或没有硫化素 (THD) 的DUV辐射,以抑制TLK1.
- 分析包括TLK1表达和酸化,细胞形态学,细胞灭绝试验,以及与DNA损伤相关的蛋白质的西方斑点.
- 在用DUV和/或THD治疗的皮下异种移植模型中评估了瘤生长.
主要成果:
- 在胰腺癌细胞中,DUV辐射诱导了TLK1酸化.
- 与DUV辐射相结合的TLK1抑制显著改变了细胞形态和增强了细胞亡.
- TLK1抑制抑制了CHK1和pCHK1的表达,MRE11抑制进一步降低了这些蛋白质,增加了亡.
- 在用DUV和THD治疗的异种移植模型中,瘤体积减少.
结论:
- TLK1酸化是细胞对DUV辐射反应的一个关键事件.
- 将DUV照射与TLK1抑制相结合,证明了胰腺癌的治疗前景.
相关概念视频
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mutations
36.3K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
36.3K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K


